Skip to main content
SpringerLink
Log in

Antineoplastic Therapy—Induced Palmar Plantar Erythrodysesthesia (‘Hand-Foot’) Syndrome

Incidence, Recognition and Management

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Palmar plantar erythrodysesthesia (PPE) is a distinctive and relatively frequent toxic reaction related to some chemotherapeutic agents. Doxorubicin, cytarabine, docetaxel, and fluorouracil are the most frequently implicated agents. PPE seems to be dose dependent and both peak drug concentration and total cumulative dose determine its occurrence.

PPE presents as a painful erythema, often preceded by paresthesia, located on the palms and soles in the context of treatment with chemotherapy. Histologically, PPE shows few specific findings. Mild spongiosis, scattered necrotic and dyskeratotic keratinocytes and vacuolar degeneration of the basal layer is seen. Dermal changes in most cases include dilated blood vessels, papillary edema, and a sparse superficial perivascular lymphohistiocytic infiltrate can be found in varying degrees in the epidermis.

Withdrawal or dose reduction of the implicated drug usually gives rise to amelioration of the symptoms. Supportive treatments such as topical wound care, elevation, and cold compresses may help to relieve the pain. Use of systemic corticosteroids, pyridoxine (vitamin B6), blood flow reduction, and, recently, topical 99% dimethyl-sulfoxide have been used with variable outcomes. It could be of interest to consider them as preventive measures when drugs with a strong association with PPE are going to be administered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Fig. 1
Fig. 2
Fig. 3
Table II
Table III
Fig. 4
Fig. 5
Fig. 6
Table IV

Similar content being viewed by others

References

  1. Zuehlke R.K. Erythematous eruption of the palms and soles associated with mitotane therapy. Dermatologica 1974; 148 (2): 90–92

    Article  PubMed  CAS  Google Scholar 

  2. Komamura H., Higashiyama M., Hashimoto K., et al. Three cases of chemotherapy-induced acral erythema. J Dermatol 1995 Feb; 22 (2): 116–121

    PubMed  CAS  Google Scholar 

  3. Amantea M., Newman M.S., Sullivan T.M., et al. Relationship of dose intensity to the induction of palmar-plantar erythrodysesthesia by pegylated liposomal doxorubicin in dogs. Hum Exp Toxicol 1999 Jan; 18 (1): 17–26

    Article  PubMed  CAS  Google Scholar 

  4. Azurdia R.M., Clark R.E., Friedmann P.S. Chemotherapy-induced acral erythema (CIAE) with bullous reaction. Clin Exp Dermatol 1999 Mar; 24 (2): 64–66

    Article  PubMed  CAS  Google Scholar 

  5. Ayash LJ, Elias A, Ibrahim J, et al. High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma. J Clin Oncol Mar; 16 (3): 1000-1007

  6. Baer M.R., King L.E., Wolff S.N. Palmar-plantar erythrodysesthesia and cytarabine. Ann Intern Med 1985 Apr; 102 (4): 556

    PubMed  CAS  Google Scholar 

  7. Banfield G.K., Crate I.D., Griffiths C.L. Long-term sequelae of palmar-plantar erythrodysaesthesia syndrome secondary to 5-fluorouracil therapy. J R Soc Med 1995 Jun; 88 (6): 356P–357P

    PubMed  CAS  Google Scholar 

  8. Bastida J., Diaz-Cascajo C., Borghi S. Chemotherapy-induced acral erythema due to Tegafur. Acta Derm Venereol 1997 Jan; 77 (1): 72–73

    PubMed  CAS  Google Scholar 

  9. Beard J.S., Smith K.J., Skelton H.G. Combination chemotherapy with 5-fluorouracil, folinic acid, and alpha-interferon producing histologic features of graft-versushost disease. J Am Acad Dermatol 1993 Aug; 29 (2 Pt 2): 325–330

    Article  PubMed  CAS  Google Scholar 

  10. Blum J.L., Jones S.E., Buzdar A.U., et al. Multicenter phase II study of capecitabine in paclitaxel refractory metastatic breast cancer. J Clin Oncol 1999 Feb; 17 (2): 485–493

    PubMed  CAS  Google Scholar 

  11. Budd G.T., Fleming T.R., Bukowsky R.M., et al. 5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: a randomized comparison. A Soutwest Oncology Group study. J Clin Oncol 1987 Feb; 5 (2): 272–277

    CAS  Google Scholar 

  12. Budman D.R., Meropol N.J., Reigner B., et al. Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine. J Clin Oncol 1998 May; 16 (5): 1795–1802

    PubMed  CAS  Google Scholar 

  13. Bunnell C.A., Winer E.P. Oral 5-FU analogues in the treatment of Breast Cancer. Oncology (Huntingt) 1998 Oct; 12 (10 Suppl. 7): 39–43

    CAS  Google Scholar 

  14. Burgdorf W.H., Gilmore W.A., Ganick R.G. Peculiar acral erythema secondary to high-dose chemotherapy for acute myelogenous leukemia. Ann Intern Med 1982 Jul; 97 (1): 61–62

    PubMed  CAS  Google Scholar 

  15. Calista D., Landi C. Cytarabine-induced acral erythema: a localized form of toxic epidermal necrolysis? J Eur Acad Dermatol Venereol 1998 May; 10 (3): 274–275

    Article  PubMed  CAS  Google Scholar 

  16. Camps C., Soler J.J., Godes M.J., et al. Toxicidad cutánea del ftorafur, síndrome manos- pies o eritrodisestesia palmoplantar. Rev Clin Esp 1991; 188: 165–166

    PubMed  CAS  Google Scholar 

  17. Cassidy J., Dirix L., Bissett D., et al. A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors. Clin Cancer Res 1998 Nov; 4 (11): 2755–2761

    PubMed  CAS  Google Scholar 

  18. Chiara S., Nobile M.T., Barzacchi C., et al. Hand-foot syndrome induced by high-dose, short-term, continuous 5-fluorouracil infusion. Eur J Cancer 1997; 33 (6): 967–969

    Article  PubMed  CAS  Google Scholar 

  19. Cohen P.R. Acral erythema: a clinical review. Cutis 1993 Mar; 51 (3): 175–179

    PubMed  CAS  Google Scholar 

  20. Comandone A., Bretti S., LaGrotta G., et al. Palmar-plantar erythrodysesthesia syndrome associated with 5-fluorouracil treatment. Anticancer Res 1993; 13: 1781–1783

    PubMed  CAS  Google Scholar 

  21. Conroy T., Geoffrois L., Guillemin F., et al. Simplified chronomodulated continuous infusion of floxuridine in patients with metastatic renal cell carcinoma. Cancer 1993 Oct 1; 72 (7): 2190–2197

    Article  PubMed  CAS  Google Scholar 

  22. Cordonnier C., Roujeau J.C., Vernant J.P., et al. Cancer Chemotherapy and acral erythema. Ann Intern Med 1982; 97: 783

    Google Scholar 

  23. Cox G.J., Robertson D.B. Toxic erythema of palms and soles associated with highdose mercaptopurine chemotherapy. Arch Dermatol 1986; 122: 1413–1414

    Article  PubMed  CAS  Google Scholar 

  24. Crider M.K., Jansen J., Norins A.L., et al. Chemotherapy-induced acral erythema in patients receiving bone marrow transplantation. Arch Dermatol 1986 Sep; 122 (9): 1023–1027

    Article  PubMed  CAS  Google Scholar 

  25. Curran C.F., Luce J.K. Fluorouracil and palmar-plantar erythrodysesthesia. Ann Intern Med 1989 Nov 15; 111 (10): 858

    PubMed  CAS  Google Scholar 

  26. De Argila D., Dominguez J.D., Iglesias L. Taxol-induced acral erythema. Dermatology 1996; 192 (4): 377–378

    Article  PubMed  Google Scholar 

  27. De Argila Fernández-Durán D., Rivera Díaz R., López Estebaranz J.L., et al. Eritema acral inducido por 5-fluorouracilo en infusión contínua. Presentación de un caso y revisión de la literatura. Actas Dermosifiliogr 1993; 84: 315–318

    Google Scholar 

  28. De Gramont A., Louvet C., André T., et al. A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of a regimen. Eur J Cancer 1998; 34 (5): 619–626

    Article  PubMed  Google Scholar 

  29. Demircay Z., Gurbuz O., Alpdogan T.B., et al. Chemotherapy-induced acral erythema in leukemic patients: a report of 15 cases. Int J Dermatol 1997 Aug; 36 (8): 593–598

    Article  PubMed  CAS  Google Scholar 

  30. Díaz-Rubio E, Aranda E., Martín M., et al. Weekly high-dose infusion of 5-fluorouracil in advanced colorectal cancer. Eur J Cancer 1990; 26; 727–729

    Article  PubMed  Google Scholar 

  31. Doyle L.A., Berg C., Bottino G., et al. Erythema and desquamation after high-dose methotrexate. Ann Intern Med 1983; 98: 611–612

    PubMed  CAS  Google Scholar 

  32. Ellerhorst J.A., Bedikian A., Ring S., et al. Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy. Oncol Rep 1999 Sep-Oct; 6 (5): 1097–1099

    PubMed  CAS  Google Scholar 

  33. Fabian C.J., Molina R., Slavik M., et al. Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion. Invest New Drugs 1990; 8: 57–63

    Article  PubMed  CAS  Google Scholar 

  34. Fariña M.C., Andrade J., Soriano M.L., et al. Eritema acral inducido por quimioterapia. Descripción de cuatro casos y revisión de la literatura. Actas Dermosifiliogr 1998; 89: 385–391

    Google Scholar 

  35. Gabizon A., Catane R., Uziely B. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 1994; 54: 987–992

    PubMed  CAS  Google Scholar 

  36. Gabra H., Cameron D.A., Lee L.E., et al. Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer. Br J Cancer 1996; 74: 2008–2012

    Article  PubMed  CAS  Google Scholar 

  37. Gordon K.B., Tajuddin A., Guitart J., et al. Hand-foot syndrome associated with liposome- encapsulated doxorubicin therapy. Cancer 1995; 75: 2169–2173

    Article  PubMed  CAS  Google Scholar 

  38. Guillaume J.C., Carp E., Rougier P., et al. Effets secondaires cutanéo-muqueux des perfusions continues de 5-fluorouracile: 12 observations. Ann Dermatol Venereol 1988; 115: 1167–1169

    PubMed  CAS  Google Scholar 

  39. Hellier I., Bessis D., Sotto A., et al. High-dose methotrexate-induced bullous variant of acral erythema. Arch Dermatol 1996 May; 132 (5): 590–591

    Article  PubMed  CAS  Google Scholar 

  40. Herzig R.H., Wolff S.N., Lazarus H.M., et al. High-dose cytosine arabinoside therapy for refractory leukemia. Blood 1983; 62: 361–369

    PubMed  CAS  Google Scholar 

  41. Hines J.D., Zakem M.H., Adelstein T.J., et al. Treatment of advanced stage colorectal adenocarcinoma with fluorouracil and high-dose leucovorin calcium: a pilot study. J Clin Oncol 1988; 6: 142–146

    PubMed  CAS  Google Scholar 

  42. Hoff P.M., Valero V., Ibrahim N., et al. Hand-foot syndrome following prolonged infusion of high doses of vinorelbine. Cancer 1998 Mar 1; 82 (5): 965–969

    Article  PubMed  CAS  Google Scholar 

  43. Ikeda H., Kawano H., Kitaura T., et al. Acral erythema associated with high-dose methotrexate infusion. Ann Pharmacother 1999 May; 33 (5): 646

    Article  PubMed  CAS  Google Scholar 

  44. Jucglà A., Sais G., Navarro M., et al. Palmoplantar keratoderma secondary to chronic acral erythema due to tegafur. Arch Dermatol 1995 Mar; 131 (3): 364–365

    Article  PubMed  Google Scholar 

  45. Kampmann K.K., Graves T., Rogers S.D. Acral erythema secondary to high-dose cytosine arabinoside with pain worsened by cyclosporine infusions. Cancer 1989 Jun 15; 63 (12): 2482–2485

    Article  PubMed  CAS  Google Scholar 

  46. Koletsky A., Jahanzeb M., Radice P., et al. A randomized phase II trial of pegylated liposomal doxorubicin (PG-LD) as second line treatment in non-small cell lung cancer (NSCLC) patients with prior exposure to platinum based therapy [abstract 1888]. Proc Am Soc Clin Oncol 1998; 17: 490A

    Google Scholar 

  47. Kroll S.S., Koller C.A., Kaled S., et al. Chemotherapy-induced acral erythema: desquamating lesions involving the hands and feet. Ann Plast Surg 1989 Sep; 23 (3): 263–265

    Article  PubMed  CAS  Google Scholar 

  48. Krulder J.W.M., Vlasveld L.T., Willemze R. Erythema and swelling of ears after treatment with cytarabine for leukemia. Eur J Cancer 1990; 26: 649–650

    Article  PubMed  CAS  Google Scholar 

  49. Leichman C.G., Leichman L., Spears C.P., et al. Prolonged continuous infusion of fluorouracil with weekly bolus leucovorin: a phase II study in patients with disseminated colorectal cancer. J Natl Cancer Inst 1993; 85: 41–44

    Article  PubMed  CAS  Google Scholar 

  50. Levine L.E., Medenica M.M., Lorincz A.L., et al. Distinctive acral erythema occurring during therapy for severe myelogenous leukemia. Arch Dermatol 1985 Jan; 121 (1): 102–104

    Article  PubMed  CAS  Google Scholar 

  51. Lokich J.J., Ahlgren J.D., Gullo J.J., et al. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program study. J Clin Oncol 1989; 7: 425–432

    PubMed  CAS  Google Scholar 

  52. Lokich J.J., Moore C. Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome. Ann Intern Med 1984; 101: 798–800

    PubMed  CAS  Google Scholar 

  53. Matsuyama J.R., Kwok K.K. A variant of the chemotherapy-associated erythrodysesthesia syndrome related to high-dose cyclophosphamide. DICP 1989 Oct; 23 (10): 776,778-9

    PubMed  CAS  Google Scholar 

  54. Meta-Analysis Group in Cancer Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. J Clin Oncol 1998 Nov; 16 (11): 3537–3541

    Google Scholar 

  55. Millot F., Auriol F., Brecheteau P., et al. Acral erythema in children receiving highdose methotrexate. Pediatr Dermatol 1999 Sep-Oct; 16 (5): 398–400

    Article  PubMed  CAS  Google Scholar 

  56. Mortimer J.E., Anderson I. Weekly fluorouracil and high-dose leucovorin: efficacy and treatment of cutaneous toxicity. Cancer Chemother Pharmacol 1990; 26: 449–452

    Article  PubMed  CAS  Google Scholar 

  57. Muggia F.M., Hainsworth J.D., Jeffers S., et al. Phase II study of liposomal doxorubicin in refractarory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. J Clin Oncol 1997 Mar; 15 (3): 987–993

    PubMed  CAS  Google Scholar 

  58. Murphy C.P., Harden E.A., Herzig R.H. Dose-related cutaneous toxicities with etoposide. Cancer 1993 May 15; 71 (10): 3153–3155

    Article  PubMed  CAS  Google Scholar 

  59. Nagore E, Sánchez-Motilla J.M., Insa A., et al. Síndrome de eritrodisestesia palmoplantar por 5-fluorouracilo: respuesta favorable al tratamiento con piridoxina. Med Cut I L A 1998; 26: 35–38

    Google Scholar 

  60. Ogawa H., Sugiyama H., Tani Y., et al. High incidence of chemotherapy-induced acral erythema in female patients with non-Hodgkin’s lymphoma treated with the VACOP-B regimen. Leuk Lymphoma 1998 Mar; 29 (1–2): 171–177

    Article  PubMed  CAS  Google Scholar 

  61. Peters W.G., Willemze R. Palmar-plantar skin changes and cytarabine. Ann Intern Med 1985; 103: 805

    PubMed  CAS  Google Scholar 

  62. Popescu R.A., Norman A., Ross P.J., et al. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol 1999 Aug; 17 (8): 2412–2418

    PubMed  CAS  Google Scholar 

  63. Portal I., Cardenal F., Garcia-del-Muro X. Etoposide-related acral erythema. Cancer Chemother Pharmacol 1994; 34 (2): 181

    Article  PubMed  CAS  Google Scholar 

  64. Revenga Arranz F., Fernandez-Duran D.A., Grande C., et al. Acute and painful erythema of the hands and feet. Acral erythema induced by chemotherapy. Arch Dermatol 1997 Apr; 133 (4): 499–500, 502-3

    Google Scholar 

  65. Rios-Buceta L, Buezo G.F., Peñas P.F., et al. Palmar-plantar erythrodysaesthesia syndrome and other cutaneous side-effects after treatment with Tegafur. Acta Derm Venereol 1997 Jan; 77 (1): 80–81

    PubMed  CAS  Google Scholar 

  66. Rongioletti F., Ballestrero A., Bogliolo F., et al. Necrotizing eccrine squamous syringometaplasia presenting as acral erythema. J Cutan Pathol 1991 Dec; 18 (6): 453–456

    Article  PubMed  CAS  Google Scholar 

  67. Samuels B.L., Vogelzang N.J., Ruane M., et al. Continuous venous infusion of doxorubicin in advanced sarcomas. Cancer Treat Rep 1987 Oct; 71 (10): 971–972

    PubMed  CAS  Google Scholar 

  68. Schuster D., Heim M.E., Decoster G., et al. Phase I–II trial of doxifluridine (5’DFUR) administered as long-term continuous infusion using a portable infusion pump for advanced colorectal cancer. Eur J Cancer Clin Oncol 1989 Nov; 25 (11): 1543–1548

    Article  PubMed  CAS  Google Scholar 

  69. Sella A., Kilbourn R., Amato R., et al. Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer. J Clin Oncol 1994 Apr; 12 (4): 683–688

    PubMed  CAS  Google Scholar 

  70. Shall L., Lucas G.S., Whittaker J.A., et al. Painful red hands: a side effect of leukaemia therapy. Br J Dermatol 1988; 119: 249–253

    Article  PubMed  CAS  Google Scholar 

  71. Silver F.S., Espinoza L.R., Hartmann R.C. Acral erythema and hydroxyurea. Ann Intern Med 1983 May; 98 (5 Pt 1): 675

    PubMed  CAS  Google Scholar 

  72. Uziely B., Jeffers S., Isacson R., et al. Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies. J Clin Oncol 1995 Jul; 13 (7): 1777–1785

    PubMed  CAS  Google Scholar 

  73. Vakalis D., Ioannides D., Lazaridou E., et al. Acral erythema induced by chemotherapy with cisplatin. Br J Dermatol 1998 Oct; 139 (4): 750–751

    Article  PubMed  CAS  Google Scholar 

  74. Vargas-Diez E., Abajo P., Fraga J., et al. Chemotherapy-induced acral erythema. Acta Derm Venereol 1999 Mar; 79 (2): 173–175

    Article  PubMed  CAS  Google Scholar 

  75. Villalona-Calero M.A., Weiss G.R., Burris H.A., et al. Phase I and pharmacokynetic study of the oral fluoropyrimidine capecitabine in combination with paclitaxel in patients with advanced solid malignancies. J Clin Oncol 1999 Jun; 17 (6): 1915–1925

    PubMed  CAS  Google Scholar 

  76. Waltzer J.F., Flowers F.P. Bullous variant of chemotherapy-induced acral erythema. Arch Dermatol 1993 Jan; 129 (1): 43–45

    Article  PubMed  CAS  Google Scholar 

  77. Weh H.J., Wilke H.J., Dierlamm J., et al. Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma. Ann Oncol 1994; 5: 233–237

    PubMed  CAS  Google Scholar 

  78. Whitlock J.A., Wells R.J., Hord J.D., et al. High-dose cytosine arabinoside and etoposide: an effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia. Leukemia 1997 Feb; 11 (2): 185–189

    Article  PubMed  CAS  Google Scholar 

  79. Zimmerman G.C., Keeling J.H., Burris H.A., et al. Acute cutaneous reactions to docetaxel, a new chemotherapeutic agent. Arch Dermatol 1995 Feb; 131 (2): 202–206

    Article  PubMed  CAS  Google Scholar 

  80. Perry M.C., editor. The chemotherapy source book. 2nd ed. Baltimore, USA: Williams & Wilkins, 1996

    Google Scholar 

  81. Vukelja S.J., Lombardo F.A., James W.D., et al. Pyridoxine for the palmar-plantar erythrodysesthesia syndrome. Ann Intern Med 1989 Oct 15; 111 (8): 688–689

    PubMed  CAS  Google Scholar 

  82. Brown J., Burck K., Black D., et al. Treatment of cytarabine acral erythema with corticosteroids. J Am Acad Dermatol 1991 Jun; 24 (6 Pt 1): 1023–1025

    Article  PubMed  CAS  Google Scholar 

  83. Titgan M.A. Prevention of palmar-plantar erythrodysesthesia associated with liposome-encapsulated doxorubicin (Doxil®) by oral dexamethasone [abstract 288]. Proc Am Soc Clin Oncol 16: 82A, 1997

    Google Scholar 

  84. Vail D.M., Chun R., Thamm D.H., et al. Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with doxorubicin containing pegylated (Stealth) liposomes: a randomized, double-blind clinical trial using a canine model. Clin Cancer Res 1998 Jun; 4 (6): 1567–1571

    PubMed  CAS  Google Scholar 

  85. Lopez A.M., Wallace L., Dorr R.T., et al. Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia. Cancer Chemother Pharmacol 1999; 44 (4): 303–306

    Article  PubMed  CAS  Google Scholar 

  86. Vukelja S.J., Baker W.J., Burris III H.A. Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with taxotere. J Natl Cancer Inst 1993 Sep 1; 85 (17): 1432–1433

    Article  PubMed  CAS  Google Scholar 

  87. Zimmerman G.C., Keeling J.H., Lowry M., et al. Prevention of docetaxel-induced erythrodysesthesia with local hypothermia. J Natl Cancer Inst 1994; 86: 557

    Article  PubMed  CAS  Google Scholar 

  88. Susser W.S., Whitaker-Worth D.L., Grant-Kels J.M. Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol 1999; 40: 367–398

    Article  PubMed  CAS  Google Scholar 

  89. Baack B.R., Burgdorf W.H. Chemotherapy-induced acral erythema. J Am Acad Dermatol 1991 Mar; 24 (3): 457–461

    Article  PubMed  CAS  Google Scholar 

  90. Valks R., Fraga J., Porras-Luque J., et al. Chemotherapy-induced eccrine squamous syringometaplasia. A distinctive eruption in patients receiving hematopoietic progenitor cells. Arch Dermatol 1997; 133: 873–878

    Article  PubMed  CAS  Google Scholar 

  91. Esteve E., Schillio Y., Vaillant L., et al. Efficacité de la corticothérapie séquentielle dans un cas d’érythème acral douloureux secondaire au 5-fluoro-uracile à fortes doses. Ann Med Interne (Paris) 1995; 146 (3): 192–193

    CAS  Google Scholar 

  92. Fitzpatrick J.E. The cutaneous histopathology of chemotherapeutic reactions. J Cutan Pathol. 1993 Feb; 20 (1): 1–14

    Article  PubMed  CAS  Google Scholar 

  93. Sanmartín O., Botella R., Guill én C. Efectos adversos cutáneous de la quimioterapia. Piel 1996 Oct; 11 (8): 406–418

    Google Scholar 

  94. Sale G.E., Lerner K.G., Barker E.A., et al. The skin biopsy in the diagnosis of acute graft-versus-host disease of man. Am J Pathol 1977; 89: 621–635

    PubMed  CAS  Google Scholar 

  95. Van Cutsem E., Findlay M., Osterwalder B., et al. Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study. J Clin Oncol 2000 Mar; 18 (6): 1337–1345

    PubMed  Google Scholar 

  96. Burnstain H.J., Manola J., Younger J., et al. Docetaxel administered on a weekly basis for metastatic breast cancer. J Clin Oncol 2000 Mar; 18 (6): 1212–1219

    Google Scholar 

  97. Becker K.W., Kienecker E.W., Dick P. A contribution to the scientific assessment of degenerative and regenerative processes of peripheral nerve fibers following axonotmesis under the systemic administration of vitamins B1, B6 and B12—light and electron microscopy findings of the saphenous nerve in the rabbit. Neurochirurgia (Stuttg) 1990 Jul; 33 (4): 113–121

    CAS  Google Scholar 

  98. Shah B.R., Santucci K., Sinert R., et al. Acute isoniazid neurotoxicity in an urban hospital. Pediatrics 1995 May; 95 (5): 700–704

    PubMed  CAS  Google Scholar 

  99. Nand S., Messmore Jr H.L., Patel R., et al. Neurotoxicity associated with systemic high-dose cytosine arabinoside. J Clin Oncol 1986 Apr; 4 (4): 571–575

    PubMed  CAS  Google Scholar 

  100. Jackson Jr D.V., Pope E.K., McMahan R.A., et al. Clinical trial of pyridoxine to reduce vincristine neurotoxicity. J Neurooncol 1986; 4 (1): 37–41

    Article  PubMed  Google Scholar 

  101. Wiernik P.H., Yeap B., Vogl S.E., et al. Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: a study of the Eastern Cooperative Oncology Group. Cancer Invest 1992; 10 (1): 1–9

    Article  PubMed  CAS  Google Scholar 

  102. Bertelli G., Gozza A., Forno G.B., et al. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study. J Clin Oncol 1995 Nov; 13 (11): 2851–2855

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Instituto Valenciano de Oncología, C/ Denia, 20-6a, 46006, Valencia, Spain

    Eduardo Nagore & Onofre Sanmartín

  2. Hospital Universitario Dr Peset Aleixandre, Valencia, Spain

    Amelia Insa

Authors
  1. Eduardo Nagore
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amelia Insa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Onofre Sanmartín
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eduardo Nagore.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nagore, E., Insa, A. & Sanmartín, O. Antineoplastic Therapy—Induced Palmar Plantar Erythrodysesthesia (‘Hand-Foot’) Syndrome. Am J Clin Dermatol 1, 225–234 (2000). https://doi.org/10.2165/00128071-200001040-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128071-200001040-00004

Keywords

Search

Navigation